We are live on ! Find out more
PWAM

Park West Asset Management Portfolio holdings

AUM $1.18B
1-Year Est. Return 47.25%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+47.25%
3 Year Est. Return
+117.62%
5 Year Est. Return
+141.43%
10 Year Est. Return
+962.32%
AUM
$2.37B
AUM Growth
+$323M
Cap. Flow
+$20.4M
Cap. Flow %
0.86%
Top 10 Hldgs %
43.37%
Holding
88
New
14
Increased
20
Reduced
30
Closed
13

Sector Composition

Rank Sector Weight
1 Communication Services 22.66%
2 Technology 22.58%
3 Consumer Discretionary 11.16%
4 Healthcare 7.99%
5 Financials 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARA
51
DELISTED
Paramount Global Class B
PARA
$10.9M 0.46%
+260,000
New +$10.1M
LEAF
52
DELISTED
Leaf Group Ltd.
LEAF
$10.2M 0.43%
2,556,187
+10,000
+0.4% +$36.8K
SPCE.WS
53
DELISTED
Virgin Galactic Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stoc
SPCE.WS
$10.1M 0.42%
+3,000,000
New +$7.2M
QTNT
54
DELISTED
Quotient Limited Ordinary Shares
QTNT
$9.83M 0.41%
25,848
-222
-0.9% -$73.6K
WSC icon
55
WillScot Mobile Mini Holdings
WSC
$4.81B
$9.56M 0.4%
+517,000
New +$8.68M
OPRA
56
Opera Ltd
OPRA
$1.83B
$9.5M 0.4%
1,026,900
-367,449
-26% -$3.6M
QTRX icon
57
Quanterix
QTRX
$174M
$9.22M 0.39%
390,000
+77,536
+25% +$1.77M
BAND
58
Bandwidth Inc
BAND
$1.48B
$8.97M 0.38%
140,000
+80,000
+133% +$4.63M
AVXL icon
59
Anavex Life Sciences
AVXL
$297M
$8.73M 0.37%
3,370,000
+120,000
+4% +$315K
OPRX icon
60
OptimizeRx
OPRX
$128M
$8.37M 0.35%
814,668
-264,468
-25% -$3M
UROV
61
DELISTED
Urovant Sciences Ltd.
UROV
$6.71M 0.28%
432,500
PLXP
62
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$6.44M 0.27%
1,473,218
PFNX
63
DELISTED
Pfenex Inc.
PFNX
$4.24M 0.18%
386,095
-499,663
-56% -$4.96M
SDC
64
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$3.93M 0.17%
+450,000
New +$4.5M
FLL icon
65
Full House Resorts
FLL
$83M
$3.7M 0.16%
1,103,766
-196,234
-15% -$571K
FTDR icon
66
Frontdoor
FTDR
$5.39B
$3.56M 0.15%
75,000
-35,000
-32% -$1.64M
GORV
67
DELISTED
Lazydays
GORV
$3.21M 0.14%
26,081
SSI
68
DELISTED
Stage Stores Inc
SSI
$2.69M 0.11%
+331,559
New +$1.28M
CDNA icon
69
CareDx
CDNA
$2.44B
$2.07M 0.09%
95,868
-115,972
-55% -$2.66M
XTNT icon
70
Xtant Medical Holdings
XTNT
$63.1M
$2.01M 0.08%
1,258,733
ACEL.WS
71
DELISTED
Accel Entertainment Inc Warrant
ACEL.WS
$1.38M 0.06%
+466,665
New +$1.23M
LGC.WS
72
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$1.33M 0.06%
2,470,000
-500,000
-17% -$223K
APVO icon
73
Aptevo Therapeutics
APVO
$5.12M
0
VKTXW
74
DELISTED
Viking Therapeutics, Inc.
VKTXW
$623K 0.03%
95,600
CVM icon
75
CEL-SCI Corp
CVM
$23.8M
$549K 0.02%
2,000

Similar funds

Park West Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Park West Asset Management held 88 positions worth $2.37B, up 16% from $2.05B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Park West Asset Management's Q4 2019 filing shows 14 new, 20 increased, 30 reduced and 13 closed positions. Its largest new stake was Burlington: 200,000 shares worth $45.6M. The largest sale was Caesars Entertainment, an estimated $81.8M.

By sector, the portfolio is most concentrated in Communication Services at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Park West Asset Management's largest Q4 2019 buy was Burlington: 200,000 shares worth $45.6M.
  • Park West Asset Management added most to Live Nation Entertainment in Q4 2019, an estimated $46.1M increase.
  • Park West Asset Management's biggest Q4 2019 reduction was Caesars Entertainment, cutting an estimated $81.8M.
  • Park West Asset Management fully exited Tandem Diabetes Care in Q4 2019, selling an estimated $32.4M.
  • Park West Asset Management's ten largest holdings make up 43% of its $2.37B portfolio in Q4 2019.
  • Park West Asset Management opened 14 new positions and closed 13 in Q4 2019.
  • Park West Asset Management's portfolio value rose 16% quarter-over-quarter to $2.37B.

Based on Park West Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.